BR9709997A - Topical gel composition containing a combination of an nosid and a xanthine derivative - Google Patents

Topical gel composition containing a combination of an nosid and a xanthine derivative

Info

Publication number
BR9709997A
BR9709997A BR9709997A BR9709997A BR9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A BR 9709997 A BR9709997 A BR 9709997A
Authority
BR
Brazil
Prior art keywords
nosid
combination
composition containing
gel composition
topical gel
Prior art date
Application number
BR9709997A
Other languages
Portuguese (pt)
Inventor
Nigel John Leeves
Francois Riahi
Original Assignee
Procter & Gamble
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter & Gamble filed Critical Procter & Gamble
Publication of BR9709997A publication Critical patent/BR9709997A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/02—Drugs for disorders of the nervous system for peripheral neuropathies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
BR9709997A 1996-06-27 1997-06-24 Topical gel composition containing a combination of an nosid and a xanthine derivative BR9709997A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9613457.2A GB9613457D0 (en) 1996-06-27 1996-06-27 Pharmaceutical compositions
PCT/US1997/011205 WO1997049405A1 (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of a nsaid and a xanthine derivative

Publications (1)

Publication Number Publication Date
BR9709997A true BR9709997A (en) 1999-08-10

Family

ID=10795959

Family Applications (1)

Application Number Title Priority Date Filing Date
BR9709997A BR9709997A (en) 1996-06-27 1997-06-24 Topical gel composition containing a combination of an nosid and a xanthine derivative

Country Status (14)

Country Link
EP (1) EP0973522A1 (en)
JP (1) JPH11513037A (en)
KR (1) KR20000022245A (en)
AU (1) AU3643897A (en)
BR (1) BR9709997A (en)
CA (1) CA2258199A1 (en)
CZ (1) CZ409198A3 (en)
GB (1) GB9613457D0 (en)
HU (1) HUP9903835A3 (en)
IL (1) IL127426A0 (en)
NO (1) NO986042L (en)
NZ (1) NZ333180A (en)
TR (1) TR199802701T2 (en)
WO (1) WO1997049405A1 (en)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6274592B1 (en) * 1997-02-04 2001-08-14 Senju Pharmaceutical Co., Ltd. Method for stabilizing arylcarboxylic acid, stabilizer thereof and aqueous solution containing stabilized arylcarboxylic acid
HUP9802716A3 (en) * 1998-11-25 2000-08-28 Chinoin Gyogyszer Es Vegyeszet Pharmaceutical composition of analgesic activity
US6368618B1 (en) 1999-07-01 2002-04-09 The University Of Georgia Research Foundation, Inc. Composition and method for enhanced transdermal absorption of nonsteroidal anti-inflammatory drugs
US20040115290A1 (en) 2001-06-20 2004-06-17 Tripp Matthew L. Modulation of inflammation by hops fractions and derivatives
US8158160B2 (en) 2001-11-13 2012-04-17 Eric Hauser Kuhrts Anti-inflammatory cyclooxygenase inhibitors
US9012402B1 (en) 2014-06-11 2015-04-21 James Blanchard Gel for topical delivery of NSAIDs to provide relief of musculoskeletal pain and methods for its preparation
US10821075B1 (en) 2017-07-12 2020-11-03 James Blanchard Compositions for topical application of a medicaments onto a mammalian body surface

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4559343A (en) * 1982-09-07 1985-12-17 Alcon Laboratories, Inc. Nonirritating aqueous ophthalmic compositions comfort formulation for ocular therapeutic agents
US5558876A (en) * 1995-03-29 1996-09-24 Alcon Laboratories, Inc. Topical ophthalmic acidic drug formulations

Also Published As

Publication number Publication date
EP0973522A1 (en) 2000-01-26
NO986042L (en) 1999-02-26
NO986042D0 (en) 1998-12-22
HUP9903835A3 (en) 2001-03-28
IL127426A0 (en) 1999-10-28
JPH11513037A (en) 1999-11-09
AU3643897A (en) 1998-01-14
GB9613457D0 (en) 1996-08-28
HUP9903835A2 (en) 2000-10-28
CA2258199A1 (en) 1997-12-31
NZ333180A (en) 2000-09-29
WO1997049405A1 (en) 1997-12-31
CZ409198A3 (en) 1999-04-14
TR199802701T2 (en) 1999-03-22
KR20000022245A (en) 2000-04-25

Similar Documents

Publication Publication Date Title
DE69630221D1 (en) STABLE ALCOHOLIC-AQUEOUS COMPOSITION
BR9610156A (en) Gel composition
PT964849E (en) SULFONYLURY DERIVATIVES AND THEIR USE IN CONTROL OF INTERLEUCIN-1 ACTUITY
FI961599A (en) 1N-alkyl-N-arylpyrimidinamines and their derivatives
BR9702553A (en) Cosmetic composition and use
FR11C0020I2 (en) Difluoroprostaglandin derivatives and their application
EE9900069A (en) Propionic acid derivatives and their uses
DK0901474T3 (en) Arylpyrimidine derivatives
ATE261942T1 (en) 6-PHENYLPYRIDINE DERIVATIVES
DE69736582D1 (en) UV-CURABLE ADHESIVE COMPOSITION AND OBJECT
BR9612426A (en) Carbomoyloxy derivatives and their application as antibacterials
DE69725465D1 (en) 6-PHENYLPYRIDYL-2-AMINE DERIVATIVES USEFUL AS NOS INHIBITORS
NO981946D0 (en) Imidazoquinazolin derivatives
BR9510229A (en) Use of a 2-alkyl or 2-aralkyl-bit derivative and composition
PT914124E (en) ANTI-TROMBOTIC AND ANTI-ATEROGENIC PHARMACEUTICAL COMPOSITION UNDERSTANDING A DERIVATIVE OF TIENOPYRIDINE AND AN INHIBITOR OF HMG-COA-REDUCTASE
NO985227L (en) Alkylaminobenzothiazole and benzoxazole derivatives
DE69732576D1 (en) TETRAHYDROBENZINDOLON DERIVATIVES
BR9709997A (en) Topical gel composition containing a combination of an nosid and a xanthine derivative
EE9900182A (en) 2-methoxyphenylpiperazine derivatives
DK0826679T3 (en) Naphthyl compounds and preparations
ID16838A (en) COMPOSITION OF DEKAFLUOROPENTANA
BR9607588A (en) Aqueous self-sustaining gel composition and use
NO983556D0 (en) Formulation and application
DE69605000T2 (en) Application unit and depilatory wax applicator
ID17419A (en) COMPOSITION OF DEKAFLUOROPENTANA

Legal Events

Date Code Title Description
B07A Application suspended after technical examination (opinion) [chapter 7.1 patent gazette]
B09B Patent application refused [chapter 9.2 patent gazette]